Clinical Trials Directory

Trials / Completed

CompletedNCT01506466

Weight Variation During Chemotherapy in Breast Cancer Patients

Weight Variation and Mechanisms Involved, During Chemotherapy in Breast Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Centre Jean Perrin · Academic / Other
Sex
Female
Age
70 Years
Healthy volunteers
Not accepted

Summary

Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients. To date, there is growing evidence for an increased risk of relapse and death in these patients who gain or lose weight. However, causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied. Thus, the investigators are conducting a prospective study to characterize weight variation in terms of body composition and to identify the mechanisms involved.

Conditions

Interventions

TypeNameDescription
OTHERblood test/ additional measurementblood test (hormonal, inflammatory, lipid and growth factors); body composition measurements; energy balance evaluation

Timeline

Start date
2011-09-01
Primary completion
2013-03-01
Completion
2014-01-01
First posted
2012-01-10
Last updated
2015-07-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01506466. Inclusion in this directory is not an endorsement.

Weight Variation During Chemotherapy in Breast Cancer Patients (NCT01506466) · Clinical Trials Directory